Fluticasone furoate, umeclidinium and vilanterol once-daily single inhaler triple therapy

Description

In this Product Explainer, Respiratory Physician Dr Adrian Barnett explains the role of fluticasone furoate, umeclidinium and vilanterol once-daily single inhaler triple therapy for the maintenance treatment of asthma in adult patients who are not adequately controlled with an ICS+LABA (5 mins).

This educational activity was developed by Healthed at the request of and with funding from GSK.

PM-AU-FVU-VID-240005 Approved September 2024.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Dr Andrew Leech

Dr Andrew Leech

Managing Paediatric Anxiety in General Practice

Prof Brendon Yee

Prof Brendon Yee

OSA – Which Test for Which Patient

Dr Sonia Davison

Dr Sonia Davison

Musculoskeletal Health in Menopause

Mr David Gardner

Mr David Gardner

AHPRA-Proof Your Practice – Social Media Risks for GPs

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Dr Adrian Barnett

expert

Dr Adrian Barnett

Respiratory Physician, Gold Coast University Hospital

Date published: 12 November 2024